We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Innospec Upgraded to Strong Buy on Robust Q1 and Prospects
Read MoreHide Full Article
Chemical maker Innospec Inc. (IOSP - Free Report) was upgraded to a Zacks Rank #1 (Strong Buy) on Jun 15. Going by the Zacks model, companies carrying a Zacks Rank #1 have higher chances of outperforming the broader market.
Why the Upgrade?
Innospec has an impressive earnings surprise history. The company has outpaced the Zacks Consensus Estimate in three of the trailing four quarters, delivering a positive average earnings surprise of 8.07%.
In the first-quarter 2017, Innospec posted better-than-expected results. The company posted adjusted earnings of $1.00 per share, exceeding the Zacks Consensus Estimate of 95 cents.
Revenues for the quarter rose about 39% year over year to $294.3 million, on the back of higher sales volume across core business segments. Sales from the Oilfield Services division surged roughly 84% year over year to $66.5 million, while Performance Chemicals unit expanded nearly three-fold to $94.5 million. The Octane Additives segment also demonstrated a stellar performance by recording roughly 61% year-over-year growth to $6.9 million.
The company is well positioned to record strong growth in all its business segments moving ahead. Innospec continues to integrate its recent acquisitions and is also pursuing other strategic buyouts to boost its portfolio.
Innospec also hiked its semi-annual dividend by 15% to 38 cents per common share for first-half 2017.
Innospec’s shares have moved up 8.4% in the last three months, outperforming the Zacks categorized Chemicals-Diversified industry’s gain of 3.7%.
Sherwin-Williams has expected long-term earnings growth rate of 11.4%.
Chemours has expected long-term earnings growth rate of 15.5%.
Huntsman has expected long-term earnings growth rate of 7%.
3 Stocks to Ride a 588% Revenue Explosion
At Zacks, we're mostly focused on short-term profit cycles, but the hottest of all technology mega-trends is starting to take hold...
By last year, it was already generating $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for those who make the right trades early. See Zacks' Top 3 Stocks to Ride This Space >>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Innospec Upgraded to Strong Buy on Robust Q1 and Prospects
Chemical maker Innospec Inc. (IOSP - Free Report) was upgraded to a Zacks Rank #1 (Strong Buy) on Jun 15. Going by the Zacks model, companies carrying a Zacks Rank #1 have higher chances of outperforming the broader market.
Why the Upgrade?
Innospec has an impressive earnings surprise history. The company has outpaced the Zacks Consensus Estimate in three of the trailing four quarters, delivering a positive average earnings surprise of 8.07%.
In the first-quarter 2017, Innospec posted better-than-expected results. The company posted adjusted earnings of $1.00 per share, exceeding the Zacks Consensus Estimate of 95 cents.
Revenues for the quarter rose about 39% year over year to $294.3 million, on the back of higher sales volume across core business segments. Sales from the Oilfield Services division surged roughly 84% year over year to $66.5 million, while Performance Chemicals unit expanded nearly three-fold to $94.5 million. The Octane Additives segment also demonstrated a stellar performance by recording roughly 61% year-over-year growth to $6.9 million.
Innospec Inc. Price and Consensus
Innospec Inc. Price and Consensus | Innospec Inc. Quote
The company is well positioned to record strong growth in all its business segments moving ahead. Innospec continues to integrate its recent acquisitions and is also pursuing other strategic buyouts to boost its portfolio.
Innospec also hiked its semi-annual dividend by 15% to 38 cents per common share for first-half 2017.
Innospec’s shares have moved up 8.4% in the last three months, outperforming the Zacks categorized Chemicals-Diversified industry’s gain of 3.7%.
Other Stocks to Consider
Other top-ranked companies in the basic materials space include The Sherwin-Williams Company (SHW - Free Report) , The Chemours Company (CC - Free Report) and Huntsman Corporation (HUN - Free Report) . All the three stocks sport a Zacks Rank #1. You can see the complete list of today’s Zacks Rank #1 stocks here.
Sherwin-Williams has expected long-term earnings growth rate of 11.4%.
Chemours has expected long-term earnings growth rate of 15.5%.
Huntsman has expected long-term earnings growth rate of 7%.
3 Stocks to Ride a 588% Revenue Explosion
At Zacks, we're mostly focused on short-term profit cycles, but the hottest of all technology mega-trends is starting to take hold...
By last year, it was already generating $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for those who make the right trades early. See Zacks' Top 3 Stocks to Ride This Space >>